• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cosmos Health Inc. - Common Stock (NQ:COSM)

    0.3627 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cosmos Health Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    BestGrowthStocks.com issues New Growth Report on Cosmos Health
    --News Direct-- 
    Via News Direct
    BestGrowthStocks.com issues New Growth Report on Cosmos Health
    NEW YORK, NY / NewsDirect / September 13th, 2023 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks... 
    Via TheNewswire.com
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Why Is Nutraceuticals Player Cosmos Health Stock Trading Higher Today? ↗
    Cosmos Health Inc (NASDAQ: COSM) announced its inaugural 2026 revenue and  
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023
    Via ACCESSWIRE
    News headline image
    Cosmos Health Q2: Revenues Slip 6%, Unfavorable Forex, Positive Adjusted EBITDA & More ↗
    Cosmos Health Inc. (NASDAQ: COSM) reported 
    Via Benzinga
    News headline image
    Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04
    Via ACCESSWIRE
    News headline image
    Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor
    Via ACCESSWIRE
    News headline image
    Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain
    Via ACCESSWIRE
    News headline image
    Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Quarter ↗
    The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Wednesday ↗
      Wednesday saw 59 companies set new 52-week lows. 
    Via Benzinga
    News headline image
    Cosmos Health Provides Update on Recent Developments, Maintains Strong Financial Position, Reaffirms Commitment to Growth, and Highlights CEO's Continued Investment Now Exceeds $15 Million
    Via ACCESSWIRE
    News headline image
    Cosmos Health And 2 Other Penny Stocks Insiders Are Buying ↗
    The Dow Jones closed higher on Monday, recording gains for the eleventh straight session. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.... 
    Via Benzinga
    News headline image
    Cosmos Health Inc. Announces Closing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
    Via ACCESSWIRE
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Why Cosmos Health (COSM) Stock Is Nosediving ↗
    Cosmos Health Inc. (NASDAQ: COSM) shares are trading lower by 17.3% to $2.05 Thursday morning after the company priced its $5.25 million registered direct offering and concurrent private placement at... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
    Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements. 
    Via Benzinga
    News headline image
    Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
    Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday. 
    Via Benzinga
    News headline image
    Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
    Via ACCESSWIRE
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
    It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning! 
    Via InvestorPlace
    News headline image
    Cosmos Health Successfully Completes Acquisition of Cana Laboratories; Anticipates to Record a Substantial Gain on Bargain Purchase
    Via ACCESSWIRE
    News headline image
    Cosmos Health Launches Chios Island, the Latest Addition to Its Mediterranation Premium Line of Supplements
    Via ACCESSWIRE
    News headline image
    Cosmos Health Successfully Completes Second Phase of CCX0722 Development, an Innovative Product for Obesity and Weight Management: Significant Step in Bringing Product to the Multi-Billion-Dollar Market
    Via ACCESSWIRE
    News headline image
    Cosmos Health Successfully Closes Acquisition of Assets from I. Bikas GP; Annual Revenue Projected to Grow by over $10 Million
    Via ACCESSWIRE
    News headline image
    Cosmos Health Expands Premium Nutritional Supplements Line Mediterranation with the Launch of Terra Creta
    Via ACCESSWIRE
    News headline image
    Cosmos Health set to join Russell Microcap Index
    Via ACCESSWIRE
    News headline image
    Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately €32M, or 70%, by the End of 2025 vs FY 2022.
    Via ACCESSWIRE
    News headline image
    Cosmos Health Reports First Quarter 2023 Financial Results; Delivers Positive Adjusted EBITDA and Significant Increase in Adjusted Net Income
    Via ACCESSWIRE
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.